Department of Biotechnology (DBT) invites proposals from Indian Companies working on Antivirals under Biotechnology Industry Partnership Programme (BIPP), a Government partnership with industry for support on a cost sharing basis for development of novel and high risk futuristic technologies mainly for viability gap funding and enhancing existing R&D capacities.
A single or consortia of Indian “for profit” company (ies) - Small, Medium or Large having DSIR* recognized in-house R&D unit(s). An Indian Company is defined as one which is registered under “The Indian Companies Act, 1956” and in which 51% (or more) of the ownership is held by Indian citizens (including NRIs).
The proposals can be submitted:
• by an Indian Company alone; or
• by an Indian Company along public sector R&D institution(s), organization(s), laboratory (ies), university (ies) etc.; or
• by a consortium of Indian Companies; or
• by a consortium of Indian Companies along with public sector R&D institution(s), organization(s), laboratory (ies), university (ies) etc.
(*Companies in the process of obtaining DSIR recognition may also apply along with the proof of application to DSIR. However, the final decision on such applications would be subject to their getting DSIR recognition)
Announcement Date: 23-11-2010
Last Submission Date: 22-12-2010 12:00 AM
© 2019 B I R A C